Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

covid

Pharmafile.com’s weekly COVID-19 news round-up

May 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus

Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …
News
mit

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

May 20, 2020 Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory

A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …
News
martin_shkreli_house_committee_on_oversight_and_government_reform_2016

Judge rejects Martin Shkreli’s prison release request to work on COVID-19 therapy

May 18, 2020 Sales and Marketing COVID-19, Martin Shkreli, coronavirus

Notorious incarcerated ex-pharma CEO Martin Shkreli has his request rejected to be released from prison in order to research a …
News
shutterstock

New study on COVID-19 immune response shows promise for vaccine development

May 18, 2020 Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

Researchers at the labs of Dr Alessandro Sette and Dr Shane Crotty at California’s La Jolla Institute for Immunology have …
News
drrrr

White House announces Dr Moncef Slaoui, the former head of GSK’s vaccine division, as the co-leader of Operation Warp Speed

May 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

President Donald Trump has announced that Dr Moncef Slaoui, the former head of GlaxoSmithKline’s vaccine division, will head up Operation …
Appointment
rose_bud

Trump announces ‘Operation Warp Speed’ to develop a COVID-19 vaccine by the end of the year

May 18, 2020 Sales and Marketing COVID-19, Trump, coronavirus

President Trump has announced a task force to quickly develop a vaccine for the US, titled Operation Warp Speed. Explaining …
News
vaccinesss

Sanofi backtracks on promise of shipping COVID-19 vaccine to the US first

May 18, 2020 Sales and Marketing COVID-19, coronavirus

Sanofi has backtracked on comments it made last week, where the company’s CEO said the US would get priority when …
News

Ex-BARDA chief warns of ‘darkest’ US winter in modern history due to COVID-19

May 18, 2020 Sales and Marketing COVID-19, coronavirus

The former head of the Biomedical Advanced Research and Development Authority (BARDA) has warned that due to the US’s handling …
News
aviv_regev

Genentech’s retiring R&D head to be replaced by MIT executive

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, appointment

Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …
Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of …
News
japan_mhlw

Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19

May 12, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir

Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …
News
laree2

What can previous outbreak modeling tell us about the COVID-19 pandemic?

May 11, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Interview, coronavirus, feature, pharma

Dr LaRee Tracy, a lecturer at San Diego State University and Director of Biostatistics at PHASTAR, led a team of …
Feature
takeda_usa_pharmaceuticals_u

Takeda’s subcutaneous Entyvio approved in Europe for maintenance of moderate to severe Crohn’s and ulcerative colitis

May 11, 2020 Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, ulcerative colitis

The European Commission has awarded marketing approval to Takeda’s subcutaneous formulation of its gut-selective biologic therapy Entyvio (vedolizumab) as a …
News
nhs_doctors

Latest large hydroxychloroquine study suggests it does not help treat COVID-19

May 11, 2020 Sales and Marketing COVID-91, coronavirus, hydroxychloroquine

The results of another study into the use of hydroxychloroquine in COVID-19 patients has cast further doubts on its effectiveness …
News
fda2outsideweb

Lynparza combo authorised in US for first-line maintenance of HRD-positive advanced ovarian cancer

May 11, 2020 Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer

Lynparza (olaparib), developed by AstraZeneca and MSD, has secured FDA approval when paired with bevacizumab as a first-line maintenance treatment …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025